~155 spots leftby Jun 2026

Quit Line Referral Support for Smoking

Recruiting in Palo Alto (17 mi)
Overseen byDanielle McCarthy, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Wisconsin, Madison
No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to understand how the Salvation Army staff can help people who use tobacco learn about and connect with no-cost treatments to help cut down or quit smoking. Researchers will gather information about the thoughts and experiences of people who smoke tobacco and receive services at the Salvation Army, as well as the experiences of the staff offering support to help treat tobacco use.

Eligibility Criteria

This trial is for adults over 18 who are involved with the Salvation Army, either receiving or providing social services, and can communicate in English, Spanish, or another language with interpreter support. It's not open to children under 18 or those unable to speak a common language.

Inclusion Criteria

I am 18 years old or older.
I can communicate in English, Spanish, or another language with available interpreter services.
Involved in the management, delivery, or receipt of social services at a participating Salvation Army site, or a member of the University of Wisconsin-Center for Tobacco Research and Intervention Outreach Team supporting Wisconsin Tobacco Quit Line implementation

Exclusion Criteria

I cannot communicate in the same language as the study team or an available interpreter.
I am under 18 years old.

Treatment Details

Interventions

  • Cognitive-Motivational Feedback (Behavioral Intervention)
  • Consumer Incentives for Immediate Referral to a Tobacco Quit Line (Behavioral Intervention)
  • Staff Tobacco Quit Line Referral Implementation Support (Behavioral Intervention)
Trial OverviewThe study tests how effective different methods are at helping tobacco users quit. This includes cognitive-motivational feedback, staff training on referring people to a Tobacco Quit Line, and offering incentives for immediate referrals.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Incentivized Immediate Wisconsin Tobacco Quit Line (WTQL) ReferralExperimental Treatment3 Interventions
In this experimental condition, Salvation Army personnel will implement an incentive strategy designed to encourage Salvation Army consumers to accept immediate referral to the WTQL. The incentive strategy will be adapted by Salvation Army personnel to fit in the local context, and staff will receive training and ongoing support in implementation of the incentive strategy. The modest incentives will be added in a staggered manner across the 2 Salvation Army sites participating in this pilot trial, after at least 3 months of implementing WTQL referral without consumer incentives for immediate calls.
Group II: Enhanced Wisconsin Tobacco Quit Line (WTQL) Referral Implementation SupportExperimental Treatment2 Interventions
Both participating sites in this pilot study will be in this experimental enhanced implementation support arm to help us iteratively enhance the feasibility, acceptability, and sustainability of implementation strategies to support WTQL referral in these sites. Salvation Army personnel at participating sites will receive implementation training and ongoing support to help enhance the fit of WTQL referral in their workflows, culture, and climate, and to enhance staff readiness to connect the consumers they serve with the WTQL. No consumer incentives for connecting with the Quit Line immediately by phone will be offered in this arm so it can serve as active comparator condition for the incentivized arm described below.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of Wisconsin Center for Tobacco Research and InterventionMadison, WI
Loading ...

Who Is Running the Clinical Trial?

University of Wisconsin, MadisonLead Sponsor
National Institutes of Health (NIH)Collaborator
National Cancer Institute (NCI)Collaborator

References